Sunil R Hingorani

8PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2026
Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer.

|May 06, 2025
Improving outcomes of patients with pancreatic cancer.

Stephan B Dreyer, Philip Beer, Sunil R Hingorani

|Dec 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.

Naomi Yamamoto, Stephanie Dobersch, Ian Loveless

|May 03, 2023
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases.

Nithya Kartha, Jessica E Gianopulos, Zachary Schrank

|Nov 29, 2022
Epithelial and stromal co-evolution and complicity in pancreatic cancer.

Sunil R Hingorani

|Feb 25, 2022
Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer.

Ingunn M Stromnes, Ayaka Hulbert, Meagan R Rollins

Pageof 2

Frequent Collaborators

2 joint publications

Sita Kugel

2 joint publications

Stephanie Dobersch

1 joint publications

Navid Farr

1 joint publications

Ravneet Vohra